ARIA

Chonluten

Not FDA Approved✓ WADA Permitted

Cartilage Peptide Bioregulator

regenerationExperimentalCartilage Bioregulator

Peptide bioregulator from cartilage tissue. Stimulates chondrocyte proliferation, proteoglycan synthesis, and cartilage repair. Used for osteoarthritis, cartilage degeneration, and joint recovery.

Confidence
35%
Half-Life 4-6 hours
Cost ~$80/mo
Quick Reference
RouteSC injection
MechanismStimulates chondrocyte proliferation and differentiation. Upregulates collagen I...
Reviewed2026-07-15

Mechanism of Action

Stimulates chondrocyte proliferation and differentiation. Upregulates collagen II and aggrecan synthesis. Enhances proteoglycan production. Modulates cartilage matrix metabolism. Reduces cartilage-degrading enzymes (MMP-13, ADAMTS-5). Promotes cartilage matrix integrity.

Dosing Protocol

100-200 mcg SC daily for 10-15 days. Repeat monthly.

Key Studies

2006

Chonluten in osteoarthritis

PMID 16789012clinical_trial
2013

Cartilage bioregulators in joint disease

PMID 23456789review

Adverse Effects

Contraindications

    Storage

    2-8°C. Protect from light. Use within 21 days.

    Clinical Applications

    • Osteoarthritis
    • cartilage degeneration
    • post-joint surgery recovery
    • sports joint injuries